In these patients, local extracorporeal radiation therapy activates and promotes the maturation of antigen-presenting cells by altering various immune-related factors in cancer cells (ATP, GM-CSF, HMGB1, etc.), promoting their influx into the lymph nodes. Here, HMGB1 is linked to cancer.